ArticleWorld journal of clinical cases2020
Erratum: Author's Affiliation Correction. Type II human epidermal growth factor receptor heterogeneity is a poor prognosticator for type II human epidermal growth factor receptor positive gastric cancer (
Akio Kaito et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.